| Use of ARINA-1 in an Intermediate Size Patient Population of Bilateral Lung Transplant Patients With CLAD Grade 0 (NCT03226431) | Duke University | 2017-12-11 |
| Study of COR388 HCl in Healthy Subjects (NCT03331900) | Cortexyme Inc. | 2017-12-11 |
| A Single Dose Escalation Study of PCSK9 Inhibitor (JS002) in Health Subjects (NCT04197817) | Shanghai Junshi Bioscience Co., Ltd. | 2017-12-11 |
| Role of Stem Cell Therapy in Interstitial Pulmonary Fibrosis (NCT03187431) | Assiut University | 2017-12-11 |
| Bioequivalence Study of Xian Risperdal Tablets Compared With Gurabo Risperdal Tablets Under Fasting and Fed Conditions in Chinese Healthy Participants (NCT03220867) | Xian-Janssen Pharmaceutical Ltd. | 2017-12-11 |
| TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery (NCT03297710) | Mayo Clinic | 2017-12-11 |
| Systemic Inflammatory Response to CCRE (NCT02847247) | University of North Carolina, Chapel Hill | 2017-12-11 |
| Project EMPOWERING: Evidence-based PrEP for Justice-Involved Women and Their Risk Networks (NCT03293290) | Yale University | 2017-12-11 |
| NEPHSTROM for Diabetic Kidney Disease (NCT02585622) | Mario Negri Institute for Pharmacological Research | 2017-12-11 |
| To Evaluate the Food Effect and the Absorption Profile of Ibuprofen Controlled-Release Tablets 600 mg in Comparison to the Reference Standard Ibuprofen Tablets in Normal Healthy Volunteers (NCT03418805) | Overseas Pharmaceuticals, Ltd. | 2017-12-11 |
| Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis (NCT03392168) | Arcutis Biotherapeutics, Inc. | 2017-12-11 |
| A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast Cancers (NCT03251378) | Hutchison Medipharma Limited | 2017-12-11 |
| Study of TTC-352 in Patients With Metastatic Breast Cancer Progressing on Endocrine Therapy (NCT03201913) | TTC Oncology, LLC | 2017-12-11 |
| HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM (NCT03596086) | David Baskin MD | 2017-12-11 |
| A Study to Evaluate Safety, Tolerability, and PD of Tegoprazan on Healthy Male Volunteers (NCT03378284) | HK inno.N Corporation | 2017-12-10 |
| Safety and Pharmacokinetic Study of Inhaled Esketamine in Healthy Volunteers (NCT03407872) | Celon Pharma SA | 2017-12-09 |
| Study of BCMA CAR-T in Multiple Myeloma (NCT03322735) | Henan Cancer Hospital | 2017-12-08 |
| Romidepsin Maintenance After Allogeneic Stem Cell Transplantation (NCT02512497) | Ohio State University Comprehensive Cancer Center | 2017-12-08 |
| Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT03017131) | Roswell Park Cancer Institute | 2017-12-08 |
| A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of Single and Multiple Ascending Doses of GDC-0334 and the Effect of Food on the Pharmacokinetics of GDC-0334 in Healthy Adult Participants (NCT03381144) | Genentech, Inc. | 2017-12-08 |
| Study of a Single Dose of PRS-060 Administered by Oral Inhalation or IV Infusion in Healthy Subjects (NCT03384290) | Pieris Australia Pty Ltd | 2017-12-08 |
| Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02833506) | Roswell Park Cancer Institute | 2017-12-08 |
| A Study of EDP-938 in Healthy Subjects (NCT03384823) | Enanta Pharmaceuticals, Inc | 2017-12-07 |
| A Study of Dulaglutide in Healthy Participants (NCT03363906) | Eli Lilly and Company | 2017-12-07 |
| Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade Using Pembrolizumab in Metastatic Non-Small Cell Lung Carcinoma (NCT03307759) | Peter MacCallum Cancer Centre, Australia | 2017-12-07 |
| A Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination With Immune Checkpoint Inhibition in Refractory Colorectal Cancer (NCT03206073) | National Cancer Institute (NCI) | 2017-12-07 |
| A Pharmacokinetic Study Comparing MB02 And US And EU Avastin® In Healthy Male Volunteers (NCT03293654) | mAbxience Research S.L. | 2017-12-07 |
| Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma (NCT03161756) | Melanoma and Skin Cancer Trials Limited | 2017-12-07 |
| Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer (NCT03211416) | Roswell Park Cancer Institute | 2017-12-07 |
| Repeat Doses of BAY 1817080 in Healthy Males & Proof of Concept in Chronic Cough Patients (NCT03310645) | Bayer | 2017-12-07 |
| Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A) (NCT02276820) | AlloVir | 2017-12-07 |
| A Study of NOV140201 (JPI-547) in Subject With Advanced Solid Tumors (NCT04335604) | Onconic Therapeutics Inc. | 2017-12-06 |
| Study of MK-7162 in Combination With Pembrolizumab (MK-3475) in Adult Participants With Advanced Solid Tumors (MK-7162-002) (NCT03364049) | Merck Sharp & Dohme LLC | 2017-12-06 |
| Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer (NCT03295227) | M.D. Anderson Cancer Center | 2017-12-06 |
| An Investigational Immuno-Therapy Study of Experimental Medication BMS-986277 Given Alone and in Combination With Nivolumab in Epithelial Cancers (NCT03363776) | Bristol-Myers Squibb | 2017-12-06 |
| Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects (NCT03382977) | VBI Vaccines Inc. | 2017-12-06 |
| Evaluate the Effects of the Environmental Change in Intestine by Antibiotics on the Pharmacokinetic Characteristics of Simvastatin in Healthy Male Volunteers (NCT03403972) | Seoul National University Hospital | 2017-12-06 |
| Role of Hyperpolarized 13C-Pyruvate MR Spectroscopy in Patients With Intracranial Metastasis Treated With (SRS) (NCT03324360) | Sunnybrook Health Sciences Centre | 2017-12-06 |
| Safety Evaluation of IV Tc 99m Tilmanocept and Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASH (NCT03332940) | Navidea Biopharmaceuticals | 2017-12-06 |
| A Study of BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid Tumors (NCT03369223) | Bristol-Myers Squibb | 2017-12-06 |
| Pembrolizumab and Ruxolitinib Phosphate in Treating Patients With Metastatic Stage IV Triple Negative Breast Cancer (NCT03012230) | Mayo Clinic | 2017-12-06 |
| Microdystrophin Gene Transfer Study in Adolescents and Children With DMD (NCT03368742) | Solid Biosciences Inc. | 2017-12-06 |
| Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria (NCT03392896) | Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 2017-12-06 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Ex-vivo Antitubercular Activity of PBTZ169 Formulation (NCT03423030) | Innovative Medicines for Tuberculosis | 2017-12-05 |
| Adipose Stem Cells for Traumatic Spinal Cord Injury (NCT03308565) | Mohamad Bydon | 2017-12-05 |
| A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas (NCT03277729) | Fred Hutchinson Cancer Center | 2017-12-05 |
| Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies (NCT03422679) | Cellestia Biotech AG | 2017-12-05 |
| A Factor IX Gene Therapy Study (FIX-GT) (NCT03369444) | University College, London | 2017-12-05 |
| A Trial of KB004 in Patients With Glioblastoma (NCT03374943) | Olivia Newton-John Cancer Research Institute | 2017-12-05 |
| Neurocognitive Decline in Patients With Brain Metastases (NCT03508752) | University of Texas Southwestern Medical Center | 2017-12-05 |
| A 6-Part Study In Healthy Volunteers To Evaluate Safety, Tolerability and Uptake Of MEDI7219 in the Body When Given as Single and Multiple Doses (NCT03362593) | MedImmune LLC | 2017-12-04 |
| Evaluation of the Effects of Cannabidiol (CBD) Compared to Delta-9-Tetrahydrocannabinol (THC) and Alprazolam (NCT03398083) | National Institute on Drug Abuse (NIDA) | 2017-12-04 |
| A Phase 1, Randomized Pharmacokinetics and Safety Study of Extended Duration Dapivirine Vaginal Rings (NCT03234400) | International Partnership for Microbicides, Inc. | 2017-12-04 |
| Safety, Reactogenicity, and Immunogenicity of mRNA-1653 in Healthy Adults (NCT03392389) | ModernaTX, Inc. | 2017-12-04 |
| A Study to Compare 2 Formulations of LY900014 in Healthy Participants (NCT03334448) | Eli Lilly and Company | 2017-12-04 |
| Class II Invariant Chain HCV Vaccine Study (NCT03688061) | University of Oxford | 2017-12-04 |
| A Study Using Healthy Volunteers Comparing Belatacept Which Has Been Manufactured By 2 Different Processes (NCT03375138) | Bristol-Myers Squibb | 2017-12-04 |
| A Study to Evaluate the Effect of Multiple Doses of CC-90001 on the Pharmacokinetics of Omeprazole, Midazolam, Warfarin, Rosuvastatin, Metformin, Digoxin, and Nintedanib in Healthy Adult Subjects (NCT03363815) | Celgene | 2017-12-04 |
| Crossover Study to Assess the Relative Bioavailability and Bioequivalence of Niraparib Tablet Compared to Niraparib Capsule (NCT03329001) | Tesaro, Inc. | 2017-12-04 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP16001 After Oral Administration in Healthy Male Volunteers (NCT03364985) | Daewoong Pharmaceutical Co. LTD. | 2017-12-03 |
| Endometrial Receptivity in Patients With Recurrent Implantation Failure as a Preparatory Step for PET (NCT03361839) | Cairo University | 2017-12-01 |
| Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty (NCT04319848) | Singapore Eye Research Institute | 2017-12-01 |
| APG-1252 in Patients With SCLC or Advanced Solid Tumors (NCT03387332) | Ascentage Pharma Group Inc. | 2017-12-01 |
| Treatment of Nonunion of Limb Fracture With Human Amniotic Epithelial Cells（hAECs） (NCT03031509) | Shanghai East Hospital | 2017-12-01 |
| Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer (NCT03310632) | Golden Biotechnology Corporation | 2017-12-01 |
| Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome (NCT03383380) | Children's Hospital of Fudan University | 2017-12-01 |
| Cardiac Uptake of Metformin, Visualized by Positron Emission Tomography (NCT03122769) | Henrik Wiggers | 2017-12-01 |
| QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHL (NCT03169790) | ImmunityBio, Inc. | 2017-12-01 |
| Combination of Immunotherapy and Hyperthermia in Advanced Malignant Mesothelioma (NCT03393858) | Capital Medical University | 2017-12-01 |
| 177Lu-EB-PSMA617 in Patients With Metastatic Castration-resistant Prostate Cancer (NCT03403595) | Peking Union Medical College Hospital | 2017-12-01 |
| Bilateral Orthotopic Lung Transplant - Bone Marrow Transplant (NCT03330795) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-12-01 |
| A Study Evaluating Safety and Efficacy of C-CAR011 in Subjects With B-NHL (NCT03299738) | Shanghai AbelZeta Ltd. | 2017-12-01 |
| A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies (NCT03329950) | Celldex Therapeutics | 2017-12-01 |
| QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy (NCT03169764) | ImmunityBio, Inc. | 2017-12-01 |
| A Trial to Evaluate Safety, Tolerability, PK and Antiviral Activity of MB-110 in Hepatitis C Virus Infected Patients (NCT02617615) | Microbio Co Ltd | 2017-12-01 |
| QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy (NCT03197571) | ImmunityBio, Inc. | 2017-12-01 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of YZJ-1139 in Healthy Participants (NCT06673927) | Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | 2017-12-01 |
| Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma (NCT03383978) | Johann Wolfgang Goethe University Hospital | 2017-12-01 |
| Endosleeve in Adolescents (NCT03778697) | King Saud University | 2017-12-01 |
| QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy (NCT03167164) | ImmunityBio, Inc. | 2017-12-01 |
| Development of a Morphine Pharmacokinetic and Pharmacodynamic Model for the Neonatal Population (NCT03035578) | The Hospital for Sick Children | 2017-12-01 |
| Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis (NCT02988401) | Johns Hopkins University | 2017-12-01 |
| An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS) (NCT03157167) | Navidea Biopharmaceuticals | 2017-12-01 |
| Daylight Photodynamic Therapy for Actinic Keratosis (NCT03322293) | University of California, San Francisco | 2017-12-01 |
| Ibrutinib and Lenalidomide in Treating Patients With Myelodysplastic Syndrome (NCT03359460) | University of California, Davis | 2017-12-01 |
| Effect of Chidamide Combined With CAT-T or TCR-T Cell Therapy on HIV-1 Latent Reservoir (NCT03980691) | Guangzhou 8th People's Hospital | 2017-12-01 |
| Intravenous Ketamine Plus Neurocognitive Training for Depression (NCT03237286) | Rebecca Price | 2017-12-01 |
| Bioequivalence and Safety Study of Bevacizumab-biosimilar (RPH-001) Compared to Bevacizumab-innovator (NCT03131700) | TRPHARM | 2017-12-01 |
| Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS) (NCT03208296) | Ascend Biopharmaceuticals Ltd | 2017-12-01 |
| Effects of AZD1775 on the PK Substrates for CYP3A, CYP2C19, CYP1A2 and on QT Interval in Patients With Advanced Cancer (NCT03333824) | AstraZeneca | 2017-12-01 |
| QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy (NCT03197584) | ImmunityBio, Inc. | 2017-12-01 |
| QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy (NCT03167177) | ImmunityBio, Inc. | 2017-12-01 |
| QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy (NCT03175666) | ImmunityBio, Inc. | 2017-12-01 |
| A Study of Modified Release Formulations of Danicopan in Healthy Adult Participants (NCT03384186) | Alexion Pharmaceuticals, Inc. | 2017-12-01 |
| Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor (NCT02831179) | Vanderbilt-Ingram Cancer Center | 2017-12-01 |
| Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of ASK120067 in Locally Advanced and Metastatic Non Small Cell Lung Cancer (NCT03502850) | Jiangsu Aosaikang Pharmaceutical Co., Ltd. | 2017-11-30 |
| BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma (NCT03119064) | Brown University | 2017-11-30 |
| A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer (NCT03343301) | Five Prime Therapeutics, Inc. | 2017-11-30 |
| Transcranial Direct Current Stimulation to Modulate Top-Down Regulation for Drug Craving in Methamphetamine Use Disorder (NCT03382379) | Laureate Institute for Brain Research, Inc. | 2017-11-30 |
| A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors (NCT03343054) | Pfizer | 2017-11-30 |